PATENT CLAIM ANALYSIS

Application Number: 16023477
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "282000"]

Abstract:
This present application disclosed a series of selective adenylyl cyclase 1 (AC1) inhibitors as a pain therapeutic. Those compounds may provide an effective method of treatment for chronic/inflammatory pain. Those compounds may also prevent opioid dependence and/or reduce opioid dependence. Both method and composition matters are within the scope of this invention.

Claim (Index 13):
The method of  claim 10 , wherein R 1  is a C 1 -C 24  alkyl, cycloalkyl, or an optionally substituted C 4 -C 24  aryl or heteroaryl.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.28889
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14382645', '15772365', '15106363', '14377478', '10512986']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7370862880877967
- 35 USC 102 Novelty (BERT): 0.5094475966210883
- Combined Prediction Score: 0.7143224189411259
- Mean Citation Score: 212.417084
- Max Citation Score: 214.96663
- Similarity Product: 137.54984929226222

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test